(Q45722404)

15 December 2017

title

Monitoring and modulation of Epstein-Barr virus loads in pediatric transplant patients (English)

1 reference

15 December 2017

0 references

Rimas J Orentas

1 reference

15 December 2017

Dennis W Schauer

1 reference

15 December 2017

Frederick W Ellis

1 reference

15 December 2017

Joanna Walczak

1 reference

15 December 2017

James T Casper

1 reference

15 December 2017

David A Margolis

1 reference

15 December 2017

publication date

1 August 2003

1 reference

Pediatric Transplantation

15 December 2017

published in

1 reference

15 December 2017

1 reference

15 December 2017

1 reference

15 December 2017

page(s)

305-314

1 reference

Feasibility of cellular adoptive immunotherapy for Epstein-Barr virus-associated lymphomas using haploidentical donors

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00090.X

Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00090.X

7 January 2021

Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00090.X

7 January 2021

Early intervention in post-transplant lymphoproliferative disorders based on Epstein-Barr viral load.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00090.X

7 January 2021

Serial measurement of Epstein-Barr viral load in peripheral blood in pediatric liver transplant recipients during treatment for posttransplant lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00090.X

7 January 2021

The management of Epstein-Barr virus associated post-transplant lymphoproliferative disorders in pediatric solid-organ transplant recipients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00090.X

7 January 2021

Determination of Epstein-Barr virus (EBV) load by RT-PCR and cellular dilution

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00090.X

7 January 2021

Detection of Epstein-Barr virus EBER sequence in post-transplant lymphoma patients with DNA dendrimers

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00090.X

7 January 2021

Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00090.X

7 January 2021

Epstein-Barr virus small RNA (EBER) genes: unique transcription units that combine RNA polymerase II and III promoter elements

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00090.X

7 January 2021

Rapid in situ hybridization for the diagnosis of latent Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00090.X

7 January 2021

Nucleic acid spot hybridization: rapid quantitative screening of lymphoid cell lines for Epstein-Barr viral DNA

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00090.X

7 January 2021

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00090.X

7 January 2021

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00090.X

7 January 2021

Serial detection of Epstein-Barr virus DNA in sera and peripheral blood leukocyte samples of pediatric renal allograft recipients with persistent mononucleosis-like symptoms defines patients at risk to develop post-transplant lymphoproliferative dis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00090.X

7 January 2021

10.1034/J.1399-3046.2003.00090.X

Identifiers

DOI

1 reference

15 December 2017

1 reference